Liquidia Corporation to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Liquidia (NASDAQ: LQDA) will participate in investor conferences on April 14–15, 2026, offering one-on-one meetings and a webcasted fireside chat.

Executives attending include CEO Dr. Roger Jeffs, COO/CFO Michael Kaseta, and Chief Business Officer Jason Adair. Webcast replay and transcript will be archived on the company Investors page for at least 30 days.

News Market Reaction – LQDA

-0.77%

-0.77% Session close to close

In the Apr 7 session, LQDA declined 0.77%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISVILLE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced it will participate in upcoming investor conferences.

2026 Raymond James Biotech Innovation Symposium
Date: Tuesday, April 14, 2026
Location: Lotte New York Palace, New York, NY
Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Chief Business Officer, will participate in one-on-one investor meetings.

25th Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 15, 2026
Location: Virtual Event
In addition to hosting one-on-one meetings, Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta will provide an update on the company's business during a fireside chat session beginning at 12:45 p.m. Eastern Time. Access to the webcast will be available on the “Investors” page of Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A replay and transcript of the webcast will be archived on the Company's website for at least 30 days.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases through precise, innovative therapies and applications of its proprietary PRINT^® Technology. PRINT enabled the creation of YUTREPIA^® (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice-daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit www.liquidia.com.

Contact Information
Investors:
Jason Adair
Chief Business Officer
919.328.4350
Jason.adair@liquidia.com

Media:
media@liquidia.com

FAQ

When will Liquidia (LQDA) present at the Raymond James Biotech Innovation Symposium in 2026?

Liquidia will attend the Raymond James Biotech Innovation Symposium on April 14, 2026. According to the company, Michael Kaseta and Jason Adair will hold one-on-one investor meetings at the Lotte New York Palace in New York, NY.

What participation will Liquidia (LQDA) have at the 25th Annual Needham Virtual Healthcare Conference?

Liquidia will participate in the Needham Virtual Healthcare Conference on April 15, 2026. According to the company, CEO Dr. Roger Jeffs and Michael Kaseta will host a fireside chat at 12:45 p.m. Eastern Time with one-on-one meetings also scheduled.

How can investors watch Liquidia's (LQDA) fireside chat webcast on April 15, 2026?

Investors can watch the webcast from the company Investors page at https://liquidia.com/investors/events-and-presentations. According to the company, a replay and transcript will be archived on the website for at least 30 days after the event.

Which Liquidia (LQDA) executives will meet investors at the April 2026 conferences?

Executives attending include CEO Dr. Roger Jeffs, COO/CFO Michael Kaseta, and Chief Business Officer Jason Adair. According to the company, Kaseta and Adair will lead one-on-one meetings while Jeffs will join the Needham fireside chat.

Will Liquidia (LQDA) provide a replay or transcript of its April 2026 investor presentation?

Yes; a replay and transcript will be available on the company's Investors page for at least 30 days. According to the company, the materials will be archived following the webcast on April 15, 2026.